Obesity and Cancer: Is there a Role for New Drugs or Old Tricks? - Dr. Rachel Perry - Yale University

Dr.RachelPerry-MODRSeminar

Schedule

Start 18 February, 2021, 12 PM

End 1 PM

Location

1280 Main St W

Hamilton

ON

Canada

Contact Info

E-Mail: modr@mcmaster.ca

Website


Rachel Perry is an Assistant Professor of Cellular & Molecular Physiology and Internal Medicine (Endocrinology) at Yale University. Her training involved the development of stable isotope tracer methods to assess metabolic physiology
and pathophysiology. Since opening her lab, Dr. Perry has focused on how obesity contributes to the cancer epidemic. Her lab uses tracer techniques to understand how novel anticancer agents, as well as an ancient technique, exercise, may slow tumor growth.

LEARNING OBJECTIVES

  1. Describe the association between hyperinsulinemia and obesity in murine models of colon and breast cancer.
  2. Identify the metabolic mechanisms by which insulin appears to drive tumor growth in the models presented.
  3. Identify multiple potential therapeutic targets for obesity-associated breast and colon cancer through reversal of hyperinsulinemia.



Accessibility for Ontarians With Disabilities Act (AODA)

 

The Faculty of Health Sciences is committed to providing a website that is accessible to the widest possible audience. If there is an accessibility issue with this website, please contact us at fhsweb@mcmaster.ca.